Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acrosomal vesicle protein 1 (SP-10; gene symbol ACRV1) is a testis-specific protein that arises during spermatogenesis within the acrosomal vesicle of developing sperm and becomes associated with the acrosomal membranes and matrix of mature sperm[1][5]. Its primary known function is likely related to the binding or penetration of the sperm to the zona pellucida—the glycoprotein layer surrounding the egg—during fertilization, making it integral to male fertility[1]. The ACRV1 gene produces several protein isoforms through alternative splicing and is localized exclusively to sperm, with no evidence of systemic expression[1]. Acrosomal vesicle protein 1 has been studied as a potential immunogen for contraceptive vaccine research, but there is no evidence that it is currently targeted by any approved therapeutic drugs[1][5]. Defects in its expression or function are presumed to contribute to male infertility through impaired acrosome function and fertilization ability[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acrosomal vesicle protein 1 (SP-10).